Ultralife (NASDAQ:ULBI) reported quarterly sales of $36.11 million which missed the analyst consensus estimate of $37.00 million by 2.41 percent. This is a 51.95 percent increase over sales of $23.76 million the same period last year.
Bausch + Lomb Announces Launch of $1.4B Proposed Financing for Acquisition of XIIDRA
Bausch + Lomb Corporation (TSX:BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that Bausch + Lomb Escrow Corp. ("Escrow Issuer"), a wholly owned
